<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Thaweethai T</submitter><funding>NHLBI NIH HHS</funding><pagination>127907</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12670331</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>68</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>In adolescents (12-17 years), it is unknown whether COVID-19 vaccination reduces progression from COVID-19 to Long COVID (LC) beyond preventing SARS-CoV-2 infection. We assessed the effect of vaccination among SARS-CoV-2 infected adolescents.&lt;h4>Methods and results&lt;/h4>Participants were recruited from over 60 US healthcare and community settings. The exposure was any COVID-19 vaccination 6 months prior to infection. The outcome was LC defined using the LC research index. Vaccinated (n = 724) and unvaccinated (n = 507) adolescents were matched on sex, infection date, and enrollment date. The risk of LC was 36 % lower (95 % CI, 17 %, 50 %) in vaccinated compared to unvaccinated participants.&lt;h4>Conclusions&lt;/h4>Vaccination reduces the risk of LC. Given the profound impact LC c</pubmed_abstract><journal>Vaccine</journal><pubmed_title>Preventive effect of vaccination on long COVID in adolescents with SARS-CoV-2 infection.</pubmed_title><pmcid>PMC12670331</pmcid><funding_grant_id>OT2 HL161847</funding_grant_id><funding_grant_id>OT2 HL156812</funding_grant_id><funding_grant_id>OT2 HL161841</funding_grant_id><pubmed_authors>Thaweethai T</pubmed_authors><pubmed_authors>Carmilani M</pubmed_authors><pubmed_authors>Milner JD</pubmed_authors><pubmed_authors>Kleinman LC</pubmed_authors><pubmed_authors>Krishnamoorthy A</pubmed_authors><pubmed_authors>Stockwell MS</pubmed_authors><pubmed_authors>Mohandas S</pubmed_authors><pubmed_authors>Fitzgerald ML</pubmed_authors><pubmed_authors>Gross RS</pubmed_authors><pubmed_authors>Rhee KE</pubmed_authors><pubmed_authors>Tantisira K</pubmed_authors><pubmed_authors>Warburton D</pubmed_authors><pubmed_authors>RECOVER-Pediatrics Consortium</pubmed_authors><pubmed_authors>Reeder HT</pubmed_authors><pubmed_authors>Salisbury AL</pubmed_authors><pubmed_authors>Kinser PA</pubmed_authors><pubmed_authors>Pant DB</pubmed_authors><pubmed_authors>Jernigan TL</pubmed_authors><pubmed_authors>Wood JC</pubmed_authors><pubmed_authors>Snowden JN</pubmed_authors><pubmed_authors>Foulkes AS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Preventive effect of vaccination on long COVID in adolescents with SARS-CoV-2 infection.</name><description>&lt;h4>Purpose&lt;/h4>In adolescents (12-17 years), it is unknown whether COVID-19 vaccination reduces progression from COVID-19 to Long COVID (LC) beyond preventing SARS-CoV-2 infection. We assessed the effect of vaccination among SARS-CoV-2 infected adolescents.&lt;h4>Methods and results&lt;/h4>Participants were recruited from over 60 US healthcare and community settings. The exposure was any COVID-19 vaccination 6 months prior to infection. The outcome was LC defined using the LC research index. Vaccinated (n = 724) and unvaccinated (n = 507) adolescents were matched on sex, infection date, and enrollment date. The risk of LC was 36 % lower (95 % CI, 17 %, 50 %) in vaccinated compared to unvaccinated participants.&lt;h4>Conclusions&lt;/h4>Vaccination reduces the risk of LC. Given the profound impact LC c</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-05T20:44:32.996Z</modification><creation>2026-05-21T03:13:10.788Z</creation></dates><accession>S-EPMC12670331</accession><cross_references><pubmed>41176968</pubmed><doi>10.1016/j.vaccine.2025.127907</doi></cross_references></HashMap>